Healthcare industry leaders, including Frier Levitt's Arielle T. Miliambro, Esq., discuss "Lessons Learned from Overturned $4.3 Million HIPAA Penalty" in the March 1st, 2021 issue of Healthcare Risk Management. This HIPAA Regulatory Alert reviews... Read More
In November 2020, the U.S. Department of Health & Human Services, Office of Inspector General (the “OIG”) issued a Special Fraud Alert to highlight the fraud and abuse risks associated with pharmaceutical and medical device company speaker... Read More
A criminal conviction relating to health care will result in an exclusion from Medicare and related health care programs. The length of the exclusion imposed depends on a variety of factors. Thinking about how to mitigate the impact of an exclusion... Read More
Frier Levitt recently obtained a $6.25 Million settlement against a Pharmacy Benefits Manager(“PBM”) on behalf of its Plan Sponsor client (“Plan”). The Plan contracted with the PBM to administer its prescription drug program, and to... Read More
The Department of Health and Human Services (HHS) recently published the long-awaited new rules related to the Anti-Kickback Statute, Civil Monetary Penalties Law, and the Stark Law (collectively, the “Final Rules”). The Final Rules are part of... Read More
On November 20, 2020, the Trump administration announced plans to scrap the Medicare Part D “rebate safe harbor,” which currently permits insurance middlemen called Pharmacy Benefits Managers (“PBMs”) to charge manufacturers substantial fees... Read More
HHS Permits Out-of-State Telehealth Providers to Render Certain Services Nationwide On December 3, 2020, the Department of Health and Human Services (“HHS”) announced a fourth amendment to its declaration under the Public Readiness and... Read More
A drug pricing program authorized under a 1992 amendment to the Public Health Service Act (Pub. L. 102-585 (1992); 42 U.S.C. § 256b), named 340B, requires drug manufacturers, in exchange for having its drugs covered by Medicaid, to sell outpatient... Read More
The U.S. Department of Health and Human Services (“HHS”) recently announced that dentists may now apply to receive funding through the CARES Act Provider Relief Fund. The original published deadline for applications to be submitted through the... Read More
Historically, prescription drug manufacturers were not required to disclose drug costs in direct-to-consumer (DTC) advertisements, but in May 2019, the rule changed. At that time, the Department of Health and Human Services (HHS), Centers for... Read More
